Tag: NYSE:HUM

  • Healthcare New Highs: UnitedHealth Group (NYSE:UNH), Unilife Corp (NASDAQ:UNIS), Amgen (NASDAQ:AMGN), Humana (NYSE:HUM)

    UnitedHealth Group Inc. (NYSE:UNH)’s stock has been on a two-week surge, hitting an all-time high for the first time earlier this month and continuing to climb even higher. Shares of the Minnetonka-based insurance company finished up 2.5 percent, to $79.96, on Wednesday, even as the broader market sagged because of worries about the Federal Reserve’s intentions concerning interest rates. UnitedHealth Group Inc. (NYSE:UNH) shares after opening at $78.07 on last trade day and at the end of the day closed at $79.96. Company price to sales ratio in past twelve months was calculated as 0.65 and price to cash ratio as 10..96. UnitedHealth Group Inc. (NYSE:UNH) showed a positive weekly performance of 3.04%.

    Unilife Corp (NASDAQ:UNIS) announced that Dennis Pyers, Vice-President and Controller of Unilife since 2010, has been named Interim CFO. Pyers replaces Richard Wieland who is leaving Unilife after four years as Executive Vice President and CFO. Dennis P. Pyers, CPA, has served as the Chief Accounting Officer, Vice President and Controller of Unilife Corporation since July 2010. Unilife Corp (NASDAQ:UNIS) shares advanced 12.55% in last trading session and ended the day on $5.74. UNIS return on equity ratio is recorded as -179.90% and its return on assets is -89.50%. Unilife Corp (NASDAQ:UNIS) yearly performance is 157.40%.

    Amgen (NASDAQ:AMGN) had its target price boosted by Citigroup Inc. to $155.00 in a report issued on Tuesday, Analyst Ratings.Net reports. They currently have a buy rating on the stock. Amgen, Inc. (NASDAQ:AMGN) shares moved down -0.70% in last trading session and was closed at $126.58, while trading in range of $125.72 – $127.99. Amgen, Inc. (NASDAQ:AMGN)year to date (YTD) performance is 11.52%.

    Humana Inc (NYSE:HUM) VP M Todoroff Christopher sold 8,000 shares of the company’s stock on the open market in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $113.20, for a total value of $905,600.00. Following the sale, the vice president now directly owns 18,225 shares in the company, valued at approximately $2,063,070. Humana Inc (NYSE:HUM) weekly performance is 5.38%. On last trading day company shares ended up $116.96. Humana Inc (NYSE:HUM) distance from 50-day simple moving average (SMA50) is 757%. Analysts mean target price for the company is $14.26.